Mercadolibre

(Delayed) portfolio review October 2024 - A month with 5 share sales and one ETF sale

Even though October was just over two weeks ago, it feels like a different time. Germany still had an (unspeakable) traffic light government, in America the race for the White House was still open and a phone call between Scholz and Putin was unthinkable.

And even though November has been much more exciting on the stock market than October so far, October was a month of major changes from a personal perspective.

Apart from stock market investments, we are slowly starting to think about building a house. As a result, for the first time in a long time I made several sales in my portfolio and therefore also cleared out a little.

Previously this year, there were only 2 sales in my portfolio: at NVIDIA I took my stake out in February and since then have only let the profits run. In addition, in March I had Encavis after the takeover bid.

There were a total of 6 sales in October. For just under €7,000 I sold my China ETF which has recovered well over the last few months.

On the equity side, I have now sold most of the Corona Hype stocks and Match, Atlassian, Shopify and Block have been sold. In addition, I have also Pfizer sold. That was another €8,000, leaving only Sea from the Corona hype times, where I will remain invested for the time being, as it covers a completely different region geographically with Southeast Asia.

My savings quota will therefore be significantly reduced for the time being due to the upcoming house building project. From just under €1,500 to €2,000, it will only be €500-600 per month for the time being

Monthly view:

In total, October was +1,7%. This corresponds to price gains of ~5.000€.

The MSCI World (benchmark) was +0.9% and the S&P500 +1.5%

Winners & losers:

A look at the winners and losers is part of the usual picture:

On the winning side is, as so often NVIDIA is at the top with almost €3,000 in share price gains. It is followed by TSMC, Bitcoin, Alphabet and Palo Alto Networks with gains of €900-1,000 each.

On the loser side above all ASML made its contribution with price losses of almost €1,400. This was followed by Bechtle, Thermo Fisher, LVMH and Nike a broader mix of stocks that have not necessarily performed well recently. Nevertheless, all 5 loser stocks are still part of my savings plans.

The performance-neutral movements in October were just under €4,600. The sales proceeds are all still in cash accounts at the moment, so they have not yet flowed out of the assets. There will be a larger dip here at some point in the future.

Current year:

My performance in the current year is +27,5% and thus above my benchmark, the MSCI World with 23.7%.

In total, my portfolio currently stands at ~331.000€. This corresponds to an absolute growth of ~€79,000 in the current year 2023. ~53.000€ of this comes from price gains, ~3.000€ from dividends / interest and ~22.000€ from additional investments.

Dividend:

• Dividends in October were 32% above the previous year at ~€150
• TSMC is in the lead with a (gross) dividend of €30 every 3 months. TSMC has already raised the dividend for next year by 30% again
• In the current year, the dividends after 10 months are +25% over the first 9 months of 2023 at ~2.350€

Buys & sells:

• I bought in October for approx. 1.500€
• As always, my savings plans were executed:
• Blue chipsNovo Nordisk $NOVO B (-2,28 %) LVMH $MC (-1,42 %) Apple $AAPL (+0,88 %) Home Depot $HD (+3,38 %) Microsoft $MSFT (+0,14 %) Nike $NKE (+3,46 %) Starbucks $SBUX (+2,2 %) Stryker $SYK (+1,96 %) Texas Instruments $TXN (+1,19 %)
• 
  GrowthCrowdstrike $CRWD (+3,74 %) MercadoLibre $MELI (+2,42 %)
• 
  ETFsMSCI World $XDWD (+1,27 %) Nikkei 225 $XDJP (+1,06 %) and the WisdomTree Global Quality Dividend Growth $GGRP (+1,05 %)
• 
  Crypto: Bitcoin $BTC (+4,56 %) and Ethereum $ETH (+9,11 %)
• 
  Sales as mentioned, there were some in October with Match $MTCH (+3,95 %) Pfizer $PFE (+0,67 %) Block $SQ (+5,05 %) Shopify $SHOP (+3,5 %) Atlassian $TEAM Invesco MSCI China All-shares $MCHS (+0,12 %)

Target 2024:

My goal for this year is to reach €300,000 in my portfolio. Due to the extremely positive market development in the current year, my portfolio already stands at ~€331,000 at the end of October.

As of mid-November and thanks to the Trump rally, my portfolio is currently approaching €350,000 and was even slightly above this level a few days ago. However, with a larger cash portion that will sooner or later flow into financing as equity.

#dividends

#dividende

#rückblick

#depotupdate

#aktie

#stocks

#etfs

#crypto

#personalstrategy

Best in class further increased.

I am now close to my first really big milestone and wanted to share my portfolio with you here for the first time.

The portfolio is structured in such a way that I have an All Word ETF and an S&P 500 ETF as a basis in order to have a deliberate additional focus on tech in the portfolio.

My largest position in the portfolio is $CTAS (+1,66 %). Of course, the share is very high with a weighting of just under 30%. However, I fully support the company's concept and have confidence in a successful future. Even if the share were to correct by 40% due to its strong performance in recent years, I wouldn't mind and would still remain invested.

All other positions are mainly for a broader coverage of the overall market.

I specifically wanted to include the consumer goods sector more strongly in my portfolio. That's why I bought the shares of

$TSCO (+1,62 %)

$CMG (+2,19 %)

$MELI (+2,42 %)

into my portfolio.

New additions to my portfolio are $RACE (+1,52 %) and the Eli Lilly share, which have been somewhat punished recently.

The share of $NU (+1,8 %) I have also added to the portfolio to better reflect the financial sector.

I also have some $BTC (+4,56 %)but I want to keep the weighting below 5% of the total portfolio.

What do you think of my portfolio?

Filled up a whole share. It is still not cheaply valued, but such setbacks need to be exploited.

Post-purchase Mercado Libre

After having built up my position in $MELI (+2,42 %) by means of a savings plan, I had the opportunity to invest in a first large tranche today after the setback.

Some thoughts on $MELI (+2,42 %) :

• high growth in the emerging region of South and Central America (Brazil, Argentina, Mexico)
• already profitable despite huge investments in growth
• interesting combination of e-commerce and FinTech

The high and profitable growth naturally has its price: the share is currently trading at a P/E ratio of 57. The free cash flow yield is nevertheless attractive and currently stands at around 5.7%. The company therefore generates a high level of cash from its operating business.

The share is comparatively volatile, so I will continue to take a cautious approach here and continuously expand the position via a savings plan.

Stay tuned

Yours Nico Uhlig

Aftermarket after quarterly figures

+26% Applovin $APP (-1,74 %)

+20% Lyft $LYFT (-0,73 %)

+13% Dutch Bros

+12% Zillow

+9% Upwork

+8% HubSpot

+5% McKesson Corporation

+5% LiveRamp

+4% Take-Two Interactive

+4% QUALCOMM $QCOM (+2,27 %)

+3% Gilead Sciences

+3% Paycor

+2% LATAM Airlines

+1% Tangier

-1% Coty

-1% Rapid7

-2% Albemarle

-4% Arm Holdings

-5% AMC Entertainment

-5% TripAdvisor

-7% Duolingo

-9% MercadoLibre $MELI (+2,42 %)

-11% Match Group

-15% Wolfspeed

#aktien
#börse
#earnings
#quartalszahlen
#etfs

MercadoLibre Income Statement | $MELI (+2,42 %)

Earnings next week

$PLTR (+0,86 %)

$SMCI

$CELH

$ARM (+0,63 %)

$CLF (+3,22 %)

$AMC

$QCOM (+2,27 %)

$DKNG (+0,9 %)

$HIMS (+3,59 %)

$ELF (+5,03 %)

$ANET (+6,84 %)

$CLOV (+1,58 %)

$SQ (+5,05 %)

$APP (-1,74 %)

$VST (+8,83 %)

$NVO (-1,95 %)

$RIVN (+2,35 %)

$DVN (+1,76 %)

$U (+5,28 %)

$WYNN (+1,21 %)

$CVS (+0,54 %)

$CEG

$TTD (+4,17 %)

$MRNA (+3,36 %)

$$BRK.A (+1,54 %) (Saturday)

$CDE (+1,18 %)

$AFRM (+5,15 %)

$MELI (+2,42 %)

$FTNT (+2,47 %)

$PINS

$ABNB (-0,18 %)

$ABX (+1,65 %)

$HL (+1,78 %)

$MAR

$IONQ

$NET (+7,27 %)

$AXON (+4,27 %)

$ALB (+0,19 %)

$DOCS (-4,52 %)

$WOLF (+2,07 %)

$BROS

$PAAS (+2 %)

$DDOG (+3,81 %)

$LCID (+3,59 %)

$TOST (+0,12 %)

$LUMN (+7,24 %)

$MLCO (+0 %)

$DOCN (+5,11 %)

$ALAB

$ACB (+3,39 %)

I struggled because the spread is extremely high. But in the end I decided to buy $WALMEX* (+0,4 %) in the end.

I am convinced of Walmart Mexico and consider the timing to be more or less "favorable".

Mexico is a growth market, and the first thing that increases with increasing prosperity, apart from body weight, is the sales of food retailers.

$MELI (+2,42 %) I may have bought it too, but that's another story 😜

Over the last few days I have been busy sorting out shares again and have now reduced my positions from 77 to 65.

------------------------------------------------------------------------------------------------

True to the motto: "With a heavy heart I am selling my rusty used car", the following positions have left my portfolio these days.

$GME (-0,84 %) with -6.22% 🤓

$MO (+0,76 %) +6,78%

$SYK (+1,96 %) +0,32%

$KDP (+0,75 %) +14,62%

$CL (+0,66 %) +12,32% 😢

$ECL (+0,61 %) +5,22%

-------------------------------------------------------------------------------------------------

However, two should follow immediately. 😜 Yes, the goal is actually to reduce stocks and not add any new ones. But these two simply fit perfectly into my growth strategy, namely $WALMEX* (+0,4 %) & $MELI (+2,42 %) In addition, -6 + 2 still makes -4, which is a WIN WIN situation.

-------------------------------------------------------------------------------------------------

But unfortunately I can't get into the 2 stocks. With $MELI (+2,42 %) I want to wait, as it is very highly valued and I see a certain downside potential in the next few weeks. With $WALMEX* (+0,4 %) I have a limit order at €2.59, but I can't get in. Although the price has already fallen below it yesterday and today. The problem is that Trade Republic has a spread of 18-24 cents per Walmex share, i.e. almost 10% 😨

-------------------------------------------------------------------------------------------------